International Hepatology Archives - Page 9 of 48

Dr.Hong You and Dr.Wei Chen’s Team Proliferative T Cell Subpopulations in the Liver Promote Fibrosis Reversal in CHB Patients After Antiviral Therapy

By Qingyuan Liu 2024.12.03

Chronic Hepatitis B (CHB) is a prevalent chronic inflammatory liver disease in China, often resulting in sustained hepatic parenchymal damage, liver fibrosis, and adverse outcomes such as cirrhosis, liver failure,…

AASLD’s Chinese Impact: Dr. Liang Peng’s Team Achieves Multiple Research Milestones in Chronic Hepatitis B and Related Liver Failure

By El Bachir MOURABIT 2024.12.03

From November 15-19, 2024, the 75th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) was held in San Diego, USA. At this prestigious event, Dr.…

AASLD 2024 | Nadege Pelletier: Exploring new hope for innovative immunotherapy for chronic hepatitis B

By Mourabit Halima 2024.12.03

Editor's note: Chronic hepatitis B (CHB) is a major public health problem worldwide. Although traditional antiviral drugs can inhibit viral replication to some extent, they are still inadequate in achieving…

AASLD 2024丨Dr. Jinlin Hou’s Team: Cost-Effectiveness of aMAP Score-Guided Individualized HCC Screening in HBsAg-Positive Populations

By El Bachir MOURABIT 2024.12.02

Hepatocellular carcinoma (HCC) imposes a significant health and economic burden on patients. Screening, recognized as an effective strategy to improve early diagnosis rates in high-risk populations, has garnered broad acknowledgment…

AASLD 2024丨Dr. Qing Xie ‘s Team: Digital Precision Screening and Risk Stratification Improve Early Detection of Liver Cancer in China

By Mourabit Halima 2024.11.29

Liver cancer poses a significant public health challenge in China, with approximately 367,700 new cases in 2022, accounting for 42.5% of global incidence. However, the five-year survival rate is a…

Chinese Contributions at AASLD 2024: Dr. Yanyan Yu and Dr. Jinghang Xu’s Team Reveal Clinical Features and Prognostic Factors of HBV-Associated Glomer

By El Bachir MOURABIT 2024.11.26

At the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meeting, two significant studies by Dr. Yanyan Yu and Dr. Jinghang Xu from Peking University First Hospital…

Chinese Expertise at AASLD 2024: Dr. Qin Ning’s Team Achieves New Breakthroughs in CHB Clinical Cure Strategies

By Mourabit Halima 2024.11.25

At the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meeting, two landmark studies from Dr. Qin Ning’s team at Tongji Hospital, Huazhong University of Science and…

AASLD 2024丨Artificial Intelligence Enhancing Early Diagnosis of Metabolic Associated Steatotic Liver Disease

By Mourabit Halima 2024.11.21

At the 2024 Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) held on November 15 in San Diego, California, a groundbreaking study highlighted the transformative…

Chinese Expertise at AASLD 2024: Dr. Huiguo Ding’s Team Advances Non-Invasive Differentiation of PSVD and Cirrhotic Portal Hypertension Using Machine

By Mourabit Halima 2024.11.21

From November 15–19, 2024, the American Association for the Study of Liver Diseases (AASLD) convened in San Diego, USA. A study led by Dr. Huiguo Ding’s team from the Beijing…

Case Study丨Dr. Jia Shang: Diagnosis and Treatment of Invasive Fungal Infection in Severe Liver Disease Patients

By Mourabit Halima 2024.11.18

Editor's Note: Invasive fungal infection (IFI) refers to a fungal infection that invades the deep tissues and organs of the human body, causing pathological changes such as tissue damage, organ…